Mangrove Partners’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-258,094
| Closed | -$6.97M | – | 528 |
|
|
2022
Q1 | $6.97M | Buy |
258,094
+125,000
| +94% | +$3.37M | 0.38% | 47 |
|
|
2021
Q4 | $3M | Sell |
133,094
-26,074
| -16% | -$588K | 0.18% | 181 |
|
|
2021
Q3 | $4.17M | Buy |
159,168
+112,192
| +239% | +$2.94M | 0.37% | 73 |
|
|
2021
Q2 | $1.5M | Buy |
+46,976
| New | +$1.5M | 0.15% | 205 |
|